Investor Stock List
Ranked #1,054 of 8,699 institutional investors

TCG Crossover Management, LLC

Palo Alto, CA

$3.40B
US stock portfolio at live prices · today +$5.6M (+0.17%)
Market closed. Prices as of Nov 20, 8:11 AM ET
Value at quarter end (Q3 2026)
$3.54B
Change from Q2 2026
−$620.7M (−14.92%)
Positions
49 · 5 new, 3 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$130M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
CGON 8.84%ABVX 8.69%SYRE 5.46%AMLX 4.81%KRSA 4.74%
StockSharesValue, live% of portfoliovs Q2 2026
CGON CG Oncology, Inc.3,670,206$301M8.84%Unchanged
ABVX ABIVAX Société Anonyme3,663,038$295M8.69%Reduced −39%
SYRE Spyre Therapeutics, Inc.1,900,582$186M5.46%Unchanged
AMLX Amylyx Pharmaceuticals, Inc.6,243,812$164M4.81%Unchanged
KRSA Korsana Biosciences, Inc.4,549,587$161M4.74%New
TNGX Tango Therapeutics, Inc.6,773,043$154M4.53%Reduced −25%
IMVT Immunovant, Inc.4,457,988$145M4.26%Unchanged
DNTH Dianthus Therapeutics, Inc.1,676,624$142M4.18%Unchanged
KOD Kodiak Sciences Inc.1,445,538$142M4.16%Unchanged
ZLAB Zai Lab Limited6,229,081$137M4.02%Added +1%
TRAX First Tracks Biotherapeutics, Inc.2,895,304$129M3.79%Unchanged
MIRM Mirum Pharmaceuticals, Inc.1,118,967$107M3.14%Added +5%
VOR Vor Biopharma Inc.5,673,078$105M3.09%Unchanged
IRON Disc Medicine, Inc.1,341,862$102M3.00%Unchanged
BCRX BioCryst Pharmaceuticals, Inc.11,020,968$80.7M2.37%Unchanged
DYN Dyne Therapeutics, Inc.4,615,144$74.0M2.18%Unchanged
AURA Aura Biosciences, Inc.10,165,357$71.0M2.09%Added +7%
XNCR Xencor, Inc.2,055,938$69.9M2.06%Reduced −16%
COGT Cogent Biosciences, Inc.2,500,003$69.4M2.04%Reduced −49%
TYRA Tyra Biosciences, Inc.3,475,980$68.6M2.02%Added +7%
SVRA Savara Inc.12,362,205$64.4M1.89%Unchanged
RLAY Relay Therapeutics, Inc.3,783,529$60.2M1.77%Reduced −11%
ADRX ADARx Pharmaceuticals, Inc.4,116,452$58.3M1.71%New
SLN Silence Therapeutics plc1,819,035$36.0M1.06%Reduced −40%
MBX MBX Biosciences, Inc.650,000$34.7M1.02%Unchanged
GLUE Monte Rosa Therapeutics, Inc.3,781,532$33.7M0.99%Reduced −18%
LBRX LB Pharmaceuticals Inc765,050$30.6M0.90%Reduced −47%
TARS Tarsus Pharmaceuticals, Inc.388,164$30.1M0.89%New
OBX Obsidian Therapeutics, Inc.2,196,138$26.7M0.78%New
TECX Tectonic Therapeutic, Inc.1,204,891$25.4M0.75%Unchanged
IPSC Century Therapeutics, Inc.17,754,430$23.4M0.69%Unchanged
ALEC Alector, Inc.10,000,000$23.0M0.68%Unchanged
AVTX Avalo Therapeutics, Inc.3,017,120$20.4M0.60%Unchanged
EDIT Editas Medicine, Inc.11,111,111$19.0M0.56%Unchanged
JANX Janux Therapeutics, Inc.1,789,617$18.4M0.54%Unchanged
MNPR Monopar Therapeutics Inc.202,242$14.2M0.42%Reduced −1%
AGMB AgomAb Therapeutics NV1,820,831$10.2M0.30%Reduced −11%
CATX Perspective Therapeutics, Inc.7,915,567$6.2M0.18%Unchanged
KRRO Korro Bio, Inc.416,301$5.1M0.15%Unchanged
TRDA Entrada Therapeutics, Inc.1,060,230$4.9M0.14%Unchanged
ARVN Arvinas, Inc.707,098$4.8M0.14%Unchanged
OCUL Ocular Therapeutix, Inc.720,323$4.2M0.12%Reduced −56%
AGEN Agenus Inc.603,892$3.7M0.11%New
CGEM Cullinan Therapeutics, Inc.406,786$3.7M0.11%Unchanged
ALXO ALX Oncology Holdings Inc.2,465,436$2.5M<0.1%Reduced −56%
AKTS Aktis Oncology, Inc.133,457$2.2M<0.1%Reduced −81%
LONA LeonaBio, Inc.464,398$1.1M<0.1%Unchanged
CNTX Context Therapeutics Inc.2,682,696$452K<0.1%Unchanged
EIKN Eikon Therapeutics, Inc.37,902$180K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
RVMD Revolution Medicines, Inc.340,899$54.3M
SRZN Surrozen, Inc.1,473,101$45.2M
ALT Altimmune, Inc.10,000,000$14.1M